DexCom, Inc. (DXCM) Shares Outstanding: 0.39
Is DexCom, Inc.’s shares outstanding high or low?
DexCom, Inc.'s shares outstanding of 0.39 is in line with its 5-year average of 0.39, around the middle of its 5-year range (0.38–0.40).
The shares outstanding for DexCom, Inc. (DXCM) is 0.39. It is below its 12-month average by 1.81% (0.40).
DXCM Shares Outstanding Chart
DXCM Average Shares Outstanding Chart
DXCM Current vs Average Shares Outstanding Chart
DXCM Shares Outstanding Metrics
SHARES OUTSTANDING
0.39
SHARES OUTSTANDING AVG TTM
0.40
SHARES OUTSTANDING AVG 3Y
0.39
SHARES OUTSTANDING AVG 5Y
0.39
SHARES OUTSTANDING AVG 10Y
0.37
SHARES OUTSTANDING AVG 15Y
0.34
SHARES OUTSTANDING AVG 20Y
0.29
CURRENT VS TTM AVG
-1.81%
CURRENT VS 3Y AVG
-0.60%
CURRENT VS 5Y AVG
+0.28%
CURRENT VS 10Y AVG
+5.96%
CURRENT VS 15Y AVG
+15.60%
CURRENT VS 20Y AVG
+36.71%
Share Structure
Shares Outstanding
390.20M
Float Shares
N/A
Stock Price
$75.62
Market Cap
$29.2B
Annual Shares Outstanding History
| Year | Weighted Average Shares | YoY Change |
|---|---|---|
| 2025 | 390.20M | -3.57% |
| 2024 | 404.63M | +4.83% |
| 2023 | 386.00M | -0.87% |
| 2022 | 389.40M | +0.65% |
| 2021 | 386.90M | +2.46% |
| 2020 | 377.60M | +3.62% |
| 2019 | 364.40M | +3.29% |
| 2018 | 352.80M | +2.20% |
| 2017 | 345.20M | +3.23% |
| 2016 | 334.40M | +4.76% |
| 2015 | 319.20M | +6.12% |
| 2014 | 300.80M | +5.77% |
| 2013 | 284.40M | +3.49% |
| 2012 | 274.80M | +4.73% |
| 2011 | 262.40M | +15.29% |
| 2010 | 227.60M | +28.31% |
| 2009 | 177.39M | +50.40% |
| 2008 | 117.95M | +4.15% |
| 2007 | 113.25M | +3.95% |
| 2006 | 108.94M | +43.77% |
| 2005 | 75.78M | +728.71% |
| 2004 | 9.14M | +5.35% |
| 2003 | 8.68M | +6.05% |
| 2002 | 8.18M | +7.89% |
| 2001 | 7.59M | +9.81% |
| 2000 | 6.91M | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
DexCom, Inc. Shares Outstanding Formula & Definition
Shares Outstanding represents the total number of shares issued by a company that are held by all shareholders. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
DexCom, Inc. Shares Outstanding FAQ
- What is the shares outstanding for DexCom, Inc. (DXCM)?
- The shares outstanding for DXCM stock is 0.39.
- Is DexCom, Inc.'s shares outstanding high or low?
- DexCom, Inc.'s shares outstanding of 0.39 is in line with its 5-year average of 0.39, around the middle of its 5-year range (0.38–0.40).
- What is the TTM average shares outstanding for DexCom, Inc. (DXCM)?
- The TTM average shares outstanding for DXCM stock is 0.40.
- What is the 3Y average shares outstanding for DexCom, Inc. (DXCM)?
- The 3Y average shares outstanding for DXCM stock is 0.39.
- What is the 5Y average shares outstanding for DexCom, Inc. (DXCM)?
- The 5Y average shares outstanding for DXCM stock is 0.39.
- What is the 10Y average shares outstanding for DexCom, Inc. (DXCM)?
- The 10Y average shares outstanding for DXCM stock is 0.37.
- What is the 15Y average shares outstanding for DexCom, Inc. (DXCM)?
- The 15Y average shares outstanding for DXCM stock is 0.34.
- What is the 20Y average shares outstanding for DexCom, Inc. (DXCM)?
- The 20Y average shares outstanding for DXCM stock is 0.29.
DexCom, Inc. Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2025-12-31 | 0.39 |
| 2024-12-31 | 0.40 |
| 2023-12-31 | 0.39 |
| 2022-12-31 | 0.39 |
| 2021-12-31 | 0.39 |
| 2020-12-31 | 0.38 |
| 2019-12-31 | 0.36 |
| 2018-12-31 | 0.35 |
| 2017-12-31 | 0.35 |
| 2016-12-31 | 0.33 |
| 2015-12-31 | 0.32 |
| 2014-12-31 | 0.30 |
| 2013-12-31 | 0.28 |
| 2012-12-31 | 0.27 |
| 2011-12-31 | 0.26 |
| 2010-12-31 | 0.23 |
| 2009-12-31 | 0.18 |
| 2008-12-31 | 0.12 |
| 2007-12-31 | 0.11 |
| 2006-12-31 | 0.11 |
| 2005-12-31 | 0.08 |
| 2004-12-31 | 0.01 |
| 2003-12-31 | 0.01 |
| 2002-12-31 | 0.01 |
| 2001-12-31 | 0.01 |
| 2000-12-31 | 0.01 |
Related Metrics
About DexCom, Inc.
DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Jacob Steven Leach